Your browser doesn't support javascript.
loading
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience.
Wu, Wen-Chi; Lin, Tzu-Yuan; Chen, Ming-Huang; Hung, Yi-Ping; Liu, Chien-An; Lee, Rheun-Chuan; Huang, Yi-Hsiang; Chao, Yee; Chen, San-Chi.
Afiliación
  • Wu WC; Division of Medical Oncology, Center of Immuno-Oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Taipei, 11217, Taiwan.
  • Lin TY; Division of Hematology, Department of Medicine, Taipei Veterans General Hospital, Taipei, 11217, Taiwan.
  • Chen MH; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, 11217, Taiwan.
  • Hung YP; Department of Radiology, Taipei Veterans General Hospital, Taipei, 11217, Taiwan.
  • Liu CA; Division of Medical Oncology, Center of Immuno-Oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Taipei, 11217, Taiwan.
  • Lee RC; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, 11217, Taiwan.
  • Huang YH; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, 11217, Taiwan.
  • Chao Y; Division of Medical Oncology, Center of Immuno-Oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Taipei, 11217, Taiwan.
  • Chen SC; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, 11217, Taiwan.
Invest New Drugs ; 40(4): 789-797, 2022 08.
Article en En | MEDLINE | ID: mdl-35477812

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos